A detailed history of King Luther Capital Management Corp transactions in Johnson & Johnson stock. As of the latest transaction made, King Luther Capital Management Corp holds 531,574 shares of JNJ stock, worth $76.8 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
531,574
Previous 539,144 1.4%
Holding current value
$76.8 Million
Previous $78.8 Million 9.32%
% of portfolio
0.37%
Previous 0.36%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$145.48 - $167.38 $1.1 Million - $1.27 Million
-7,570 Reduced 1.4%
531,574 $86.1 Million
Q2 2024

Aug 12, 2024

SELL
$144.38 - $157.78 $2.87 Million - $3.14 Million
-19,905 Reduced 3.56%
539,144 $78.8 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $3.27 Million - $3.43 Million
-21,046 Reduced 3.63%
559,049 $88.4 Million
Q4 2023

Feb 09, 2024

SELL
$145.6 - $158.88 $7.2 Million - $7.86 Million
-49,476 Reduced 7.86%
580,095 $90.9 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $2.16 Million - $2.42 Million
-13,864 Reduced 2.15%
629,571 $98.1 Million
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $312,867 - $336,704
2,027 Added 0.32%
643,435 $107 Million
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $409,194 - $488,324
2,709 Added 0.42%
641,408 $99.4 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $2.59 Million - $2.91 Million
16,183 Added 2.6%
638,699 $113 Million
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $301,687 - $335,702
-1,870 Reduced 0.3%
622,516 $102 Million
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $349,498 - $386,528
-2,078 Reduced 0.33%
624,386 $111 Million
Q1 2022

May 11, 2022

BUY
$158.14 - $179.59 $607,573 - $689,984
3,842 Added 0.62%
626,464 $111 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $297,202 - $329,757
-1,906 Reduced 0.31%
622,622 $107 Million
Q3 2021

Nov 10, 2021

SELL
$161.5 - $179.47 $314,117 - $349,069
-1,945 Reduced 0.31%
624,528 $101 Million
Q2 2021

Aug 13, 2021

BUY
$159.48 - $171.07 $899,307 - $964,663
5,639 Added 0.91%
626,473 $103 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $897,755 - $999,865
-5,865 Reduced 0.94%
620,834 $102 Million
Q4 2020

Feb 10, 2021

BUY
$137.11 - $157.38 $260,920 - $299,494
1,903 Added 0.3%
626,699 $98.6 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $19,793 - $21,690
141 Added 0.02%
624,796 $93 Million
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $390,680 - $471,661
-3,033 Reduced 0.48%
624,655 $87.8 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $12.1 Million - $16.8 Million
-109,089 Reduced 14.81%
627,688 $82.3 Million
Q4 2019

Feb 12, 2020

SELL
$127.5 - $146.44 $12.4 Million - $14.3 Million
-97,466 Reduced 11.68%
736,777 $107 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $11 Million - $12.3 Million
-86,674 Reduced 9.41%
834,243 $108 Million
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $8,787 - $9,664
67 Added 0.01%
920,917 $128 Million
Q1 2019

May 10, 2019

SELL
$125.72 - $139.79 $225,038 - $250,224
-1,790 Reduced 0.19%
920,850 $129 Million
Q4 2018

Feb 12, 2019

SELL
$122.84 - $147.84 $342,355 - $412,030
-2,787 Reduced 0.3%
922,640 $119 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $1.15 Million - $1.35 Million
-9,480 Reduced 1.01%
925,427 $128 Million
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $4.22 Million - $4.66 Million
-35,332 Reduced 3.64%
934,907 $113 Million
Q1 2018

May 08, 2018

SELL
$125.1 - $148.14 $869,069 - $1.03 Million
-6,947 Reduced 0.71%
970,239 $124 Million
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $7.69 Million - $8.42 Million
58,607 Added 6.38%
977,186 $137 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $119 Million - $124 Million
918,579
918,579 $119 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.